Raymond J. Henley Iii

Array ( [id] => 3731817 [patent_doc_number] => 05635539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Stable emulsions of highly fluorinated organic compounds' [patent_app_type] => 1 [patent_app_number] => 8/652158 [patent_app_country] => US [patent_app_date] => 1996-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3968 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635539.pdf [firstpage_image] =>[orig_patent_app_number] => 652158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664575 [patent_doc_number] => 05668114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'NADH and NADPH pharmaceuticals for treating hypertension' [patent_app_type] => 1 [patent_app_number] => 8/646898 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3384 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668114.pdf [firstpage_image] =>[orig_patent_app_number] => 646898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731764 [patent_doc_number] => 05693671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'L-glutamine therapy for sickle cell diseases and thalassemia' [patent_app_type] => 1 [patent_app_number] => 8/640512 [patent_app_country] => US [patent_app_date] => 1996-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 7925 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693671.pdf [firstpage_image] =>[orig_patent_app_number] => 640512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624918 [patent_doc_number] => 05612379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Modafinil for the treatment of sleep apneas and ventilatory disorders of central origin' [patent_app_type] => 1 [patent_app_number] => 8/564286 [patent_app_country] => US [patent_app_date] => 1996-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 871 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612379.pdf [firstpage_image] =>[orig_patent_app_number] => 564286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621108 [patent_doc_number] => 05614526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Use of phenoxy-piperzine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/639384 [patent_app_country] => US [patent_app_date] => 1996-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2413 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614526.pdf [firstpage_image] =>[orig_patent_app_number] => 639384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647246 [patent_doc_number] => 05637614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => '6,7-disubstituted-2-aminotetralines and pharmaceutical compositions containing the same' [patent_app_type] => 1 [patent_app_number] => 8/639431 [patent_app_country] => US [patent_app_date] => 1996-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6014 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637614.pdf [firstpage_image] =>[orig_patent_app_number] => 639431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621329 [patent_doc_number] => 05688797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Treatment of acute central nervous system injury with piperazine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/639908 [patent_app_country] => US [patent_app_date] => 1996-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2319 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688797.pdf [firstpage_image] =>[orig_patent_app_number] => 639908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833731 [patent_doc_number] => 05712301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Use of dexmedetomidine for treating ethanol-induced neurodegeneration' [patent_app_type] => 1 [patent_app_number] => 8/602745 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 10 [patent_no_of_words] => 1876 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712301.pdf [firstpage_image] =>[orig_patent_app_number] => 602745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687972 [patent_doc_number] => 05696101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Oxidized cellulose and vitamin E blend for topical hemostatic applications' [patent_app_type] => 1 [patent_app_number] => 8/633272 [patent_app_country] => US [patent_app_date] => 1996-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3473 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696101.pdf [firstpage_image] =>[orig_patent_app_number] => 633272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575207 [patent_doc_number] => 06469009 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Pharmaceutical compositions for the treatment of rhinitis' [patent_app_type] => B1 [patent_app_number] => 08/629144 [patent_app_country] => US [patent_app_date] => 1996-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4222 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469009.pdf [firstpage_image] =>[orig_patent_app_number] => 08629144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731762 [patent_doc_number] => 05635535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Method for increasing blood glucose levels' [patent_app_type] => 1 [patent_app_number] => 8/628859 [patent_app_country] => US [patent_app_date] => 1996-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635535.pdf [firstpage_image] =>[orig_patent_app_number] => 628859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3740896 [patent_doc_number] => 05753656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Method for treating spinocerebellar degeneration' [patent_app_type] => 1 [patent_app_number] => 8/632412 [patent_app_country] => US [patent_app_date] => 1996-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4486 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753656.pdf [firstpage_image] =>[orig_patent_app_number] => 632412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4026223 [patent_doc_number] => 05883126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Pharmacological use of certain cystine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/619681 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2343 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883126.pdf [firstpage_image] =>[orig_patent_app_number] => 619681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814229 [patent_doc_number] => 05710181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Inhibition of nitric oxide formation in inflammatory bowel disease' [patent_app_type] => 1 [patent_app_number] => 8/620833 [patent_app_country] => US [patent_app_date] => 1996-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9134 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710181.pdf [firstpage_image] =>[orig_patent_app_number] => 620833 [rel_patent_id] =>[rel_patent_doc_number] =>)